Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | BAD | Q92934 | 1/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CTRC | Q99895 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7208190 | 0.96 | ALDH1A1 (0.47) | ALDH1A1HPGDMAPTMAPK1GAA | |
| SCHEMBL2787728 | 0.85 | SELL (0.47) | ALDH1A1HPGDMAPK1KDM4EBCL2L1 | |
| SCHEMBL368712 | 0.81 | BCL2L1 (0.41) | ALDH1A1HPGDMAPTMAPK1ALOX15 | |
| SCHEMBL23713391 | 0.81 | SELL (0.47) | ALDH1A1HPGDMAPTMAPK1TDP1 | |
| SCHEMBL6416867 | 0.81 | PDK2 (0.42) | ALDH1A1HPGDMAPTGAASMN1; SMN2 | |
| SCHEMBL19330760 | 0.77 | PDK2 (0.42) | ALDH1A1HPGDMAPTGAAALOX15 | |
| SCHEMBL27350945 | 0.77 | HSP90AB1 (0.42) | ALDH1A1HPGDMAPTMAPK1GAA | |
| SCHEMBL20421306 | 0.77 | ALDH1A1 (0.40) | ALDH1A1HPGDMAPTMAPK1GAA | |
| SCHEMBL9668378 | 0.76 | BCL2L1 (0.37) | MAPK1L3MBTL1BCL2L1BADNQO1 | |
| SCHEMBL31359858 | 0.76 | BCL2L1 (0.52) | ALDH1A1HPGDL3MBTL1KDM4EBCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3880683-B1 | MONOHYDRATE POTASSIUM SALT OF A THIENOPYRIDONE DERIVATIVE AND ITS PREPARATION PROCESS | POXEL (FR) | 2023-11-01 | — | — | EP | claimed |
| CN-113166168-A | Potassium salt monohydrate of thienopyridone derivative and preparation method thereof | 博希尔公司 | 2021-07-23 | — | — | CN | claimed |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | claimed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | claimed |
| US-12319700-B2 | Monohydrate potassium salt of a thienopyridone derivative and its preparation process | POXEL (FR) | 2025-06-03 | — | — | US | disclosed |
| US-12310949-B2 | Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD) | POXEL (FR) | 2025-05-27 | — | — | US | disclosed |
| US-20250154164-A1 | MONOHYDRATE POTASSIUM SALT OF A THIENOPYRIDONE DERIVATIVE AND ITS PREPARATION PROCESS | POXEL (FR) | 2025-05-15 | — | — | US | disclosed |
| CN-115335048-B | Use of thienopyridone derivatives for the treatment of adrenoleukodystrophy or adrenomyeloneuropathy | 博希尔公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-115361949-B | Use of thienopyridone derivatives in the treatment of autosomal dominant polycystic kidney disease ADPKD | 博希尔公司 | 2025-03-11 | — | — | CN | disclosed |
| EP-4125885-B1 | USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF DIABETIC NEPHROPATHY | POXEL (FR) | 2024-12-25 | — | — | EP | disclosed |
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | Ryvu Therapeutics S.A. (PL) | 2024-12-10 | — | — | US | disclosed |
| EP-4125886-B1 | USE OF THIENOPYRIDONE DERIVATIVES FOR THE TREATMENT OF ADRENOLEUCODYSTROPHY OR ADRENOMYELONEUROPATHY | POXEL (FR) | 2024-11-27 | — | — | EP | disclosed |
| CN-113166168-A | Potassium salt monohydrate of thienopyridone derivative and preparation method thereof | 博希尔公司 | 2021-07-23 | — | — | CN | disclosed |
| EP-3807264-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2021-04-21 | — | — | EP | disclosed |
| WO-2019238786-A1 | MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | Ryvu Therapeutics S.A. (PL) | 2019-12-19 | — | — | WO | disclosed |
| US-8227426-B2 | Chiral complexes of ascorbic acid with natural antioxidant and anti-inflammatory ketones including aloe, citrus, ginger, and mango for skin and hair care | ISLAND KINETICS INC. (US) | 2012-07-24 | — | — | US | disclosed |
| US-20110059907-A1 | Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care | ISLAND KINETICS INC. (US) | 2011-03-10 | — | — | US | disclosed |
| US-20080255228-A1 | Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | disclosed |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | disclosed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059907-A1 | Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care | GLA, LPO, PLOD3 | ALDH1A1 110/4885HPGD 774/4885MAPT 2800/4885 |
| US-12162863-B2 | Modulators of stimulator of interferon genes (STING) | STING1, IRF3, CGAS | ALDH1A1 4462/4885HPGD 296/4885MAPT 1787/4885 |
| US-12319700-B2 | Monohydrate potassium salt of a thienopyridone derivative and its preparation process | SLC10A1, SLC5A2, TALDO1 | ALDH1A1 867/4885HPGD 171/4885MAPT 1184/4885 |
| US-20250154164-A1 | MONOHYDRATE POTASSIUM SALT OF A THIENOPYRIDONE DERIVATIVE AND ITS PREPARATION PROCESS | SLC10A1, TALDO1, SLC5A2 | ALDH1A1 918/4885HPGD 185/4885MAPT 1134/4885 |
| US-12310949-B2 | Use of a thienopyridone derivative in the treatment of autosomal dominant polycystic kidney disease (ADPKD) | PKD1, PKD2, PFKP | ALDH1A1 1520/4885HPGD 194/4885MAPT 1076/4885 |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | PSMB1, PLOD3, CUTA | ALDH1A1 330/4885HPGD 1094/4885MAPT 1630/4885 |
| US-20080255228-A1 | Ascorbic Acid Complexes for Skin Care Including Treatment of Dark Skin & Wrinkles | PROC, COL1A1, CUTA | ALDH1A1 35/4885HPGD 725/4885MAPT 1443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.